Current Value
$3.601 Year Return
Current Value
$3.601 Year Return
Yahoo
As we step into January 2025, the U.S. stock market is experiencing a downturn with major indices like the S&P 500 and Nasdaq Composite sliding due to rising Treasury yields and mixed economic data. In this climate, investors often look for opportunities in less conventional areas such as penny stocks, which can offer growth potential at lower price points despite their historical reputation as high-risk investments. While the term "penny stock" may seem outdated, these smaller or newer...
Yahoo
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that members of its management team will participate in the 43rd Annual J.P. Morgan Healthcare Conference. OraSure’s presentation is scheduled for Thursday, January 16, 2025 at 9:00 a.m. PT. A live webcast and replay of the presentation will be available in the “Events and Presentations” section of OraSur
Yahoo
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, January 7th by OraSure Technologies, Inc. (NASDAQ: OSUR), please note that the first sentence of the release (read "OraQuick® HIV Self-Test that will increase access to HIV testing for adolescents.") is incomplete. The corrected release follows: OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announ
Yahoo
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraQuick® HIV Self-Test that will increase access to HIV testing for adolescents. The change expands the approved age range to include individuals 14 years of age and older for the OraQuick® HIV Self-Test. Previously the test was approved for use in those 17 and older. According to the most recent data available from the Centers for Disease Control & Prevention, it is estimated that 19 percent of new HIV diagnoses in the United States were among
Yahoo
OraSure announces acquisition of Sherlock Biosciences to strengthen its molecular diagnostics portfolio.
SeekingAlpha
Fulgent Genetics is a biotech company with a profitable COVID-19 diagnostics segment that will be negligible going forward. Read why I rate FLGT stock a Buy.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
XOS | 0.20% | $27.70M | -63.14% | 0.00% |
ES | -0.22% | $20.38B | -2.20% | 5.13% |
VSTA | -0.29% | $182.79M | -46.10% | 0.00% |
HLN | 0.35% | $41.19B | +5.32% | 1.74% |
DHT | 0.35% | $1.73B | -2.28% | 9.17% |
CB | 0.35% | $103.88B | +13.25% | 1.40% |
ED | 0.42% | $30.54B | -3.79% | 3.76% |
PEP | -0.42% | $195.70B | -14.72% | 3.72% |
ABEO | -0.42% | $241.26M | +5.71% | 0.00% |
DUK | 0.45% | $81.78B | +7.53% | 3.89% |
PSQH | -0.48% | $167.01M | -23.48% | 0.00% |
AEP | 0.50% | $49.80B | +14.75% | 3.75% |
FATBB | 0.61% | $88.50M | -7.04% | 10.87% |
AON | -0.65% | $75.59B | +16.41% | 0.76% |
SCKT | 0.68% | $10.57M | +23.01% | 0.00% |
MPC | 0.68% | $45.72B | -9.65% | 2.37% |
CLX | 0.68% | $19.50B | +9.96% | 3.07% |
BACK | -0.75% | $2.56M | -43.83% | 0.00% |
VIRT | -0.78% | $2.98B | +81.55% | 2.80% |
CLRB | 0.78% | $11.65M | -91.96% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -14.00% | $19.99B | +5.68% | 1.23% |
MCK | -13.05% | $73.85B | +19.87% | 0.46% |
HUSA | -12.78% | $21.99M | -1.18% | 0.00% |
QTTB | -11.91% | $40.68M | -68.88% | 0.00% |
CME | -11.30% | $82.59B | +16.03% | 4.54% |
LPTH | -10.96% | $124.15M | +146.46% | 0.00% |
EDR | -9.77% | $9.29B | +27.94% | 0.80% |
MNOV | -7.70% | $96.13M | +30.67% | 0.00% |
PGR | -7.64% | $138.02B | +39.50% | 2.50% |
CYD | -7.62% | $413.89M | +19.04% | 3.78% |
TPVG | -6.69% | $272.08M | - | 18.62% |
QNTM | -6.38% | $6.79M | -94.15% | 0.00% |
ALL | -6.30% | $47.93B | +19.84% | 2.06% |
VHC | -6.08% | $28.01M | +19.97% | 0.00% |
MSDL | -5.93% | $1.82B | +0.42% | 9.78% |
HRL | -5.84% | $16.50B | -5.53% | 3.77% |
BROS | -5.67% | $6.51B | +105.35% | 0.00% |
BTCT | -5.60% | $20.70M | -28.47% | 0.00% |
MNST | -5.57% | $48.37B | -15.77% | 0.00% |
QXO | -5.39% | $6.41B | -84.42% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GTLS | 46.10% | $8.35B | +46.71% | 0.00% |
GPRO | 42.65% | $167.14M | -67.27% | 0.00% |
EDIT | 42.47% | $104.01M | -86.11% | 0.00% |
XPER | 41.75% | $411.99M | -19.67% | 0.00% |
NOVT | 41.49% | $5.30B | -5.27% | 0.00% |
ALRM | 41.26% | $2.94B | -5.20% | 0.00% |
ILMN | 40.50% | $21.68B | +1.63% | 0.00% |
AEIS | 40.46% | $4.46B | +15.79% | 0.35% |
ENVA | 40.05% | $2.49B | +73.27% | 0.00% |
CRL | 39.99% | $9.52B | -12.00% | 0.00% |
VCYT | 39.84% | $3.22B | +56.64% | 0.00% |
KN | 38.81% | $1.71B | +15.10% | 0.00% |
CAR | 38.73% | $2.97B | -47.32% | 0.00% |
FLYW | 38.72% | $2.21B | -13.97% | 0.00% |
BAND | 38.43% | $440.16M | +17.13% | 0.00% |
PACB | 38.23% | $575.11M | -68.70% | 0.00% |
IAC | 38.07% | $3.56B | -17.43% | 0.00% |
ALKT | 38.07% | $3.43B | +37.26% | 0.00% |
ZNTL | 37.98% | $195.98M | -80.72% | 0.00% |
ARW | 37.96% | $5.89B | -3.07% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
UNG | -0.31% | $790.37M | 1.06% |
BUXX | -0.34% | $190.00M | 0.25% |
CLOI | 0.50% | $792.86M | 0.4% |
ULST | 0.51% | $539.69M | 0.2% |
ICLO | 0.51% | $287.26M | 0.2% |
GBIL | 0.66% | $5.82B | 0.12% |
YEAR | 0.72% | $1.18B | 0.25% |
PWZ | 0.78% | $705.44M | 0.28% |
MMIN | 0.82% | $482.57M | 0.3% |
CORN | 0.92% | $63.58M | 0.2% |
BCD | 1.10% | $233.64M | 0.3% |
VRIG | 1.39% | $1.13B | 0.3% |
CCOR | -1.42% | $83.85M | 1.18% |
FTSM | -1.50% | $6.16B | 0.45% |
WEAT | -1.52% | $119.67M | 0.28% |
DBB | 1.82% | $107.54M | 0.77% |
XHLF | -1.92% | $939.87M | 0.03% |
DBC | -2.00% | $1.30B | 0.87% |
KCCA | 2.18% | $116.13M | 0.87% |
FLTR | 2.25% | $1.95B | 0.14% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -18.82% | $195.31M | 0.85% |
TAIL | -16.55% | $65.56M | 0.59% |
DBA | -11.88% | $790.77M | 0.93% |
CTA | -10.78% | $497.20M | 0.76% |
USDU | -10.20% | $381.18M | 0.5% |
TPMN | -9.04% | $41.63M | 0.65% |
DUSB | -8.72% | $923.50M | 0.15% |
SGOV | -8.69% | $30.83B | 0.09% |
UUP | -8.25% | $607.07M | 0.77% |
USCI | -8.17% | $193.45M | 1.07% |
DBE | -6.80% | $48.12M | 0.77% |
MINT | -6.72% | $12.00B | 0.35% |
AGZD | -6.13% | $142.77M | 0.23% |
EQLS | -5.84% | $9.16M | 1% |
TBLL | -5.81% | $2.00B | 0.08% |
KMLM | -5.71% | $337.46M | 0.9% |
XBIL | -5.53% | $641.82M | 0.15% |
DBO | -5.18% | $214.31M | 0.77% |
BOXX | -5.04% | $4.68B | 0.1949% |
GSG | -4.75% | $1.02B | 0.75% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RSPA | 53.41% | $270.45M | 0% |
PBE | 47.64% | $254.47M | 0.58% |
IBB | 47.56% | $6.45B | 0.45% |
ARKG | 47.52% | $1.14B | 0.75% |
GNOM | 45.56% | $71.69M | 0.5% |
BBH | 45.19% | $399.16M | 0.35% |
FBT | 44.96% | $1.14B | 0.56% |
QQA | 44.93% | $147.54M | 0% |
KOMP | 44.82% | $2.11B | 0.2% |
VIOV | 44.34% | $1.40B | 0.15% |
RZV | 44.17% | $247.62M | 0.35% |
ESML | 44.15% | $1.89B | 0.17% |
SPSM | 44.04% | $12.41B | 0.03% |
IJR | 43.87% | $87.67B | 0.06% |
IJS | 43.80% | $7.50B | 0.18% |
SLYV | 43.57% | $3.96B | 0.15% |
NUSC | 43.42% | $1.23B | 0.31% |
XHE | 43.40% | $220.80M | 0.35% |
SMMD | 43.38% | $1.37B | 0.15% |
VTWO | 43.34% | $12.36B | 0.1% |